PANCGATE
Clinical research
Puerta de Hierro University Hospital
·Majadahonda, Madrid ·

The group has worked on initiatives to promote hospital care quality, clinical trials with drugs (I-III), prehabilitation in patients with localized disease and collaboration with other institutions (IMDEA).

It is a multidisciplinary group dedicated mainly to healthcare activities that works in close collaboration with the biobank. Research activities are embedded in the daily clinical activity.

Main publications in pancreatic cancer:

  1. Cámara JC, Martin-Valadés JI, López-Alfonso A, et al. Clinical outcomes of FOLFIRINOX and gemcitabine - nab paclitaxel for metastatic pancreatic cancer in the real world setting Fernando Franco. Clin Transl Oncol. 2021; 23(4): 812-19.
  2. Ruiz-Casado A, Franco F, Manso M, et al. Some unanswered questions about elderly patients with metastatic pancreatic cancer. J Geriatr Oncol. 2020; 11(6): 1032-33. 
  3. Ruiz-Casado A, Gutiérrez D, Juez I. Erysipeloid rash: a rare adverse event induced by gemcitabine. J Cancer Res Ther. 2015; 11(4): 1024. 
Ana Ruíz Casado

Principal Investigator

Group members

  • Ana Ruiz Casado
  • Antonio Sánchez Ruiz
  • Lourdes Gutiérrez Sanz
  • Mariano González-Haba Ruiz
  • Belén Agudo Castillo
  • Daniel de la Iglesia
  • Manuel Jiménez Garrido
  • Jose Luis Lucena
  • Alberto Pueyo
  • Matías Cea
  • Antonio Sánchez
More information

Other groups

Angiogenesis Group – Alfredo Martínez Ramírez

The Angiogenesis Group is part of the Oncology Area of the Biomedical Research Center of La Rioja (CIBIR), located in Logroño, Spain. As the name implies, the Angiogenesis Group focuses on the process of angiogenesis in relation to cancer and other relevant diseases...

See all groups